Claude L. Hughes – författare

Written by leading research scientists, this book integrates current knowledge of toxicology and human health through coverage of environmental toxicants, genetic / epigenetic mechanisms, and carcinogenicity. Provides information on lifestyle choices that can reduce cancer riskOffers a systematic approach to identify mutagenic, developmental and reproductive toxicantsHelps readers develop new animal models and tests to assess toxic impacts of mutation and cancer on human healthExplains specific cellular and molecular targets of known toxicants operating through genetic and epigenetic mechanisms

This first volume chronicles the early stages of the outbreak and world-wide spread of SARS-Cov-2 (COVID-19) and delineates the role of several disciplines in therapeutic and control measures. Documenting the epidemiologic response from China, the clinical evaluation, pathology and intial therapeutics that were available during the first 6 months and onwards of the outbreak, this book records how the response to the pandemic was mounted and how various branches of science and research combined to rapidly expand our understanding of the disease.

These volumes chronicle the outbreak and world-wide spread of SARS-Cov-2 (COVID-19) and delineates the role of several disciplines in therapeutic and control measures. Designing safe and effective antiviral drugs are extremely challenging, the drug or chemical must interfere with the virus life cycle without harming the host organism's cells or systems. Viral variation and mutation is another major difficulty in developing and applying appropriate vaccines, antiviral drugs and interventions. By addressing considerations of efficacy and safety of drugs and chemicals used to combat COVID-19, virtually in real-time, these books document and highlight the advances in science and place the toxicology, pharmaceutical science, public health and medical community in a better position to advise in future epidemics.

This second volume chronicles the later stages of the outbreak of SARS-Cov-2 (COVID-19) and delineates the role of several disciplines in therapeutic and control measures highliting the response from specific coutries of note and efforts to repurpose and produce new therapeutics and vaccines. By addressing considerations of efficacy and safety of drugs and chemicals used to combat COVID-19, virtually in real-time, this book documents and highlights the advances in science and place the toxicology, pharmaceutical science, public health and medical community in a better position to advise in future epidemics.

Bringing together adistinguished interdisciplinary team of contributors, this volumeprovides a comprehensive exploration of translational toxicology—a systematicapproach to developing therapeutic interventions that can protect against,mitigate, or reverse the effects of exposures. In particular, the bookaddresses modes of action and biomarkers, developmental risks of exposures, andpotential translational toxicology therapeutics. The result is a compellingapplication of developmental toxicology in a new therapeutic discipline that isdestined to become part of standard medical practice.TranslationalToxicology: Defining a New Therapeutic Discipline is an essential text for regulatory authorities, scientists, andphysicians who are concerned with environmental exposures, public health, nutrition,and pharmaceutical research and development. Basic science, epidemiological,and clinical investigators will also find this book a significant resource.